Clovis Oncology to Announce Second Quarter 2016 Financial Results and Host Webcast Conference Call on August
8
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2016 financial results on Monday, August 8, 2016, after
the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m.
ET that day to discuss the company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets
of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is
most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.
Clovis Oncology
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com
or
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160726006235/en/